Current Challenges and Future Perspectives of Antimicrobial Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 31 May 2026
Special Issue Editors
Interests: natural products; antioxidants; phytochemicals; nutrivigilance; toxicology; dendrimers; drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery; drug design and synthesis; structural characterization; biological activity evaluation; structure-activity relationship; medicinal chemistry; pharmacovigilance
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Current challenges in antimicrobial therapy focus on the urgent global crisis of antimicrobial resistance that manifests when microorganisms, such as bacteria, fungi, or viruses, through various mechanisms, undergo resistance against the current therapeutic arsenal.
This Special Issue aims to provide valuable insights into the topic of antimicrobial therapy (antibiotics, antimycobacterials, antifungals, and antivirals) in the context of the emergence of antimicrobial resistance, through a diverse collection of articles and reviews.
Ongoing research, public awareness and education, and international collaboration play an important role in combating AMR and preserving the efficacy of antimicrobials for future generations.
Dr. Carmen Maximiliana Dobrea
Dr. Anca-Maria Arseniu
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotics, antifungals, antimicrobial resistance, antimicrobial stewardship, drug safety and efficacy, resistance mechanisms
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
